Life-threatening disseminated tuberculosis as a complication of TNF-α blockade in an adolescent

European Journal of Pediatrics

Volumn 170, Issue 10, 2011, Pages 1337-1342

  Hess, Steffen ^a   Hospach, Toni ^a   Nossal, Robert ^a   Dannecker, Günther ^a   Magdorf, Klaus ^b   Uhlemann, Frank ^a  

^a OLGAHOSPITAL   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Adalimumab; Miliary; Paradoxical reaction; SAPHO (synovitis, acne, pustulosis, hyperostosis, osteitis); TNF antagonists; Tuberculosis

Indexed keywords

ADALIMUMAB; ADRENALIN; AMOXICILLIN; AMPHOTERICIN B LIPID COMPLEX; C REACTIVE PROTEIN; CIPROFLOXACIN; CLARITHROMYCIN; DEXAMETHASONE; ETHAMBUTOL; ISONIAZID; MEROPENEM; MIDAZOLAM; MILRINONE; MOXIFLOXACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PYRAZINAMIDE; RIFAMPICIN; SALAZOSULFAPYRIDINE; STEROID; STREPTOMYCIN; THALIDOMIDE; VANCOMYCIN;

ABDUCENS NERVE PARALYSIS; ADJUVANT THERAPY; ADOLESCENT; ARTHRITIS; ARTICLE; ARTIFICIAL VENTILATION; ATAXIA; BRAIN VENTRICLE PERITONEUM SHUNT; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; CLONIC SEIZURE; CONFUSION; CONSCIOUSNESS DISORDER; COUGHING; CREATININE BLOOD LEVEL; DYSPNEA; EMERGENCY WARD; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; FLACCID PARALYSIS; GRANULOMA; HUMAN; HYPERTRANSAMINASEMIA; INTENSIVE CARE UNIT; INTERFERON GAMMA RELEASE ASSAY; INTRACRANIAL TUBERCULOMA; INTUBATION; LACTATE BLOOD LEVEL; LEUKOCYTE COUNT; LIMB WEAKNESS; LUMBAR PUNCTURE; MENINGITIS; MILIARY TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NERVE CONDUCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOMYELITIS; OXYGEN SATURATION; PAIN; PANIC; PERICARDIAL EFFUSION; PLEOCYTOSIS; PLEURA EFFUSION; POLYMERASE CHAIN REACTION; POLYNEUROPATHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PUSTULOSIS PALMOPLANTARIS; RECURRENT DISEASE; SAPHO SYNDROME; SEPTIC SHOCK; SOMNOLENCE; SPEECH DISORDER; TACHYCARDIA; THORAX RADIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREMOR; TUBERCULOSIS; TUBERCULOUS MENINGITIS; VASOCONSTRICTION;

ACQUIRED HYPEROSTOSIS SYNDROME; ADOLESCENT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTITUBERCULAR AGENTS; AZA COMPOUNDS; DRUG THERAPY, COMBINATION; DYSPNEA; ETHAMBUTOL; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; QUINOLINES; SEVERITY OF ILLNESS INDEX; SHOCK, SEPTIC; TREATMENT OUTCOME; TUBERCULOSIS, MILIARY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80054739801     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-011-1501-y     Document Type: Article

References (35)

1. JWC Alffenaar R van Altena HJ Bökkerink, et al. 2009 Pharmacokinetics of moxifloxacin in cerebrospinal fluid and plasma in patients with tuberculous meningitis Clin Infect Dis 49 1080 1082 19712035 10.1086/605576 1:CAS:528:DC%2BD1MXhtlehs7rO
2. SM Arend AMS Leyten WPJ Franken, et al. 2007 A patient with de novo tuberculosis during anti-tumor necrosis factor-α therapy illustrating diagnostic pitfalls and paradoxical response to treatment Clin Infect Dis 45 1470 1475 17990230 10.1086/522993 1:CAS:528:DC%2BD2sXhsVOqsb3L (Pubitemid 351411877)
3. K Ben Abdelghani DG Dran JE Gottenberg, et al. 2010 Tumor necrosis factor-alpha blockers in SAPHO syndrome J Rheumatol 37 1699 1704 20472920 10.3899/jrheum.091086 1:CAS:528:DC%2BC3cXhtFaht7zM
4. TK Blackmore L Manning WJ Taylor, et al. 2008 Therapeutic use of infliximab in tuberculosis to control severe paradoxical reaction of the brain and lymph nodes Clin Infect Dis 47 e83 e85 18840076 10.1086/592695 1:CAS:528:DC%2BD1cXhsVeqs7jE
5. D Buonsenso D Serranti P Valentini 2010 Management of central nervous system tuberculosis in children: light and shade Eur Rev Med Pharmacol Sci 14 845 853 21222370 1:STN:280:DC%2BC3M7gsFKktg%3D%3D
6. P Brassard A Kezouh S Suissa 2006 Antirheumatic drugs and the risk of tuberculosis Clin Infect Dis 43 717 722 16912945 10.1086/506935 1:CAS:528:DC%2BD28XpvFSktrw%3D (Pubitemid 44330734)
7. R Breen C Smith H Bettinson, et al. 2004 Paradoxical reactions during tuberculosis treatment in patients with and without HIV co-infection Thorax 59 704 707 15282393 10.1136/thx.2003.019224 1:STN:280:DC%2BD2cznvFCltw%3D%3D (Pubitemid 39061536)
8. L Carmona JJ Gómez-Reino V Rodríguez-Valverde, et al. 2005 Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists Arthritis Rheum 52 1766 1772 15934089 10.1002/art.21043 1:CAS:528:DC%2BD2MXlvFChur0%3D (Pubitemid 40852885)
9. DV Cooray R Moran D Khanna, et al. 2008 Screening, re-screening and treatment of PPD positivity in patients on anti-TNFa therapy (abstract) Arthritis Rheum 58 S546 S547
10. RP Dellinger MM Levy JM Carlet, et al. 2008 Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008 Intensive Care Med 34 17 60 18058085 10.1007/s00134-007-0934-2
11. D Eleftheriou T Gerschman N Sebire, et al. 2010 Biologic therapy in refractory chronic non-bacterial osteomyelitis of childhood Rheumatology 49 1505 1512 20430869 10.1093/rheumatology/keq122 1:CAS:528:DC%2BC3cXptFGlsrk%3D
12. AL Endean SM Barry SA Young-Min 2009 Possible miliary tuberculosis during adalimumab therapy with negative γ-IFN release assays Rheumatology 48 319 320 19109314 10.1093/rheumatology/ken469 1:CAS:528:DC%2BD1MXisVSmtrY%3D
13. C Garcia-Vidal S Rodriguez-Fernández J Martínez-Lacasa, et al. 2005 Paradoxical response to antituberculous therapy in infliximab-treated patients with disseminated tuberculosis Clin Infect Dis 40 756 759 15714425 10.1086/427941 (Pubitemid 40381354)
14. S George L Papa L Sheils, et al. 1996 Septic shock due to disseminated tuberculosis Clin Infect Dis 22 188 189 8825004 10.1093/clinids/22.1.188 1:STN:280:DyaK28vit1ertQ%3D%3D (Pubitemid 26022049)
15. JT Jacob AK Mehta MK Leonard 2009 Acute forms of tuberculosis in adults Am J Med 122 12 17 19114163 10.1016/j.amjmed.2008.09.018
16. B Kampmann E Whittaker A Williams, et al. 2009 Interferon-gamma release assays do not identify more children with active tuberculosis than the tuberculin skin test Eur Respir J 33 1374 1382 19196815 10.1183/09031936. 00153408 1:CAS:528:DC%2BD1MXoslyht7g%3D
17. K Magdorf AK Detjen 2008 Proposed management of childhood tuberculosis in low-incidence countries Eur J Pediatr 167 927 938 18470534 10.1007/s00431-008- 0730-1
18. M Magrey MA Khan 2009 New insights into synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome Curr Rheumatol Rep 11 329 333 19772827 10.1007/s11926-009-0047-8
19. AS Malipeddi R Rajendran G Kallarackal 2007 Disseminated tuberculosis after anti-TNFα treatment Lancet 369 162 17223480 10.1016/S0140-6736(07) 60078-6 (Pubitemid 46073136)
20. G Meintjes RJ Wilkinson C Morroni, et al. 2010 Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome AIDS 24 2381 2390 20808204 1:CAS:528:DC%2BC3cXhtFaqsLnO
21. P Michel C Barbier Y Loubière, et al. 2002 Three cases of septic shock due to tuberculosis without HIV pathology Intensive Care Med 28 1827 1828 12447531 10.1007/s00134-002-1526-9 (Pubitemid 35435490)
22. C Moreno J Taverne A Mehlert, et al. 1989 Lipoarabinomannan from Mycobacterium tuberculosis induces the production of tumor necrosis factor from human and murine macrophages Clin Exp Immunol 76 240 245 2503277 1:CAS:528:DyaL1MXkslKiurs%3D (Pubitemid 19150395)
23. F Piana LR Codecasa P Cavallerio, et al. 2006 Use of a t-cell based test for detection of tuberculosis infection among immunocompromised patients Eur Respir J 28 31 34 16540502 10.1183/09031936.06.00110205 1:STN:280: DC%2BD28vivVehuw%3D%3D (Pubitemid 44914257)
24. JF Schoeman G Fieggen N Seller, et al. 2006 Intractable intracranial tuberculous infection responsive to thalidomide: report of four cases J Child Neurol 21 301 308 16900926 10.1177/08830738060210040801 (Pubitemid 43891127)
25. JF Schoeman P Springer AJ van Rensburg, et al. 2004 Adjunctive thalidomide therapy for childhood tuberculous meningitis: results of a randomized study J Child Neurol 19 250 257 15163089 10.1177/088307380401900402 (Pubitemid 38660206)
26. S Shenoi CA Wallace 2010 Tumor necrosis factor inhibitors in the management of juvenile idiopathic arthritis: an evidence-based review Paediatr Drugs 12 367 377 21028916 10.2165/11532610-000000000-00000
27. I Solovic M Sester JJ Gomez-Reino, et al. 2010 The risk of tuberculosis related to TNF antagonist therapies: a TBNET consensus statement Eur Respir J 36 5 1185 1206 20530046 10.1183/09031936.00028510 1:CAS:528:DC%2BC3MXhtVWqtA%3D%3D
28. F Tubach D Salmon P Ravaud, et al. 2009 Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy Arthritis Rheum 60 1884 1894 19565495 10.1002/art.24632 1:CAS:528:DC%2BD1MXptlKktLo%3D
29. RS Wallis 2009 Infectious complications of tumor necrosis factor blockade Curr Opin Infect Dis 22 403 409 19491672 10.1097/QCO.0b013e32832dda55 1:CAS:528:DC%2BD1MXnvVOnsbs%3D
30. RS Wallis 2008 Mathematical modeling of the cause of tuberculosis during tumor necrosis factor blockade Arthritis Rheum 58 947 952 18383389 10.1002/art.23285 (Pubitemid 351563995)
31. RS Wallis 2008 Tumour necrosis factor antagonists: structure, function, and tuberculosis risks Lancet Infect Dis 8 601 611 18922482 10.1016/S1473- 3099(08)70227-5 1:CAS:528:DC%2BD1cXht1Omsr%2FP
32. RS Wallis MS Broder JY Wong, et al. 2004 Granulomatous infectious diseases associated with TNF antagonists Clin Infect Dis 38 1261 1265 15127338 10.1086/383317 1:STN:280:DC%2BD2c3islCksg%3D%3D (Pubitemid 38608568)
33. RS Wallis MS Broder JY Wong, et al. 2004 Granulomatous infections due to tumor necrosis factor blockade: correction Clin Infect Dis 39 1254 1256 15486857 10.1086/424455 (Pubitemid 40169331)
34. RS Wallis C van Vuuren S Potgieter 2009 Adalimumab treatment of life-threatening tuberculosis Clin Infect Dis 48 1429 1432 19364287 10.1086/598504
35. Yoo WH (2010) Multiple organ tuberculosis of lung, pleura, and peritoneum in ankylosing spondylitis during adalimumab therapy. Rheumatol Int. doi: 10.1007/s00296-009-1357-x